{
  "documentMetadata": {
    "title": "Sinusitis, Intubation Associated",
    "sourceFile": "Sinusitis, Intubation Associated.pdf",
    "lastUpdated": "2025-04-22"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Sinusitis in hospitalized patients as a complication of nasotracheal intubation or nasogastric tube.",
        "Remove nasotracheal tube and if fever persists, recommend sinus aspiration (by ENT if available) for culture/sensitivity and nasal PCR for MRSA prior to empiric therapy."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Gram-negative bacilli (47%) (Pseudomonas sp., Acinetobacter sp., E. coli are commonly encountered)",
        "Gram positives (Staph. aureus) (35%)",
        "Yeasts (18%)",
        "Polymicrobial (80%)"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Imipenem-cilastatin",
            "dose": "0.5 gm",
            "route": "IV",
            "frequency": "q6h",
            "connector": "or"
          },
          {
            "drug": "Meropenem",
            "dose": "1 gm",
            "route": "IV",
            "frequency": "q8h"
          }
        ]
      }
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "condition": "MRSA suggestive on gram-stain",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "route": "IV",
            "frequency": "q8-12h"
          }
        ],
        "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator); alternative is trough of 15-20 µg/mL"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Ceftazidime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q8h",
            "connector": "or"
          },
          {
            "drug": "Cefepime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q12h",
            "connector": "+"
          },
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "route": "IV",
            "frequency": "q8-12h"
          }
        ],
        "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator); alternative target is trough of 15-20 µg/mL"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Data supports obstructing tube leading to accumulation of sinus fluid that may ultimately harbor invasive bacteria and/or serve as reservoir of bacteria that are aspirated and cause pneumonia (J Intensive Care Med 2019;34:844)",
        "After 7 days of nasotracheal or gastric tubes, 95% of patients have x-ray \"sinusitis\" (fluid in sinuses), but on transnasal puncture only 38% are culture positive, Am J Respir Crit Care Med 150:776, 1994.",
        "For patients requiring mechanical ventilation with nasotracheal tube for ",
        "1 week, bacterial sinusitis occurs in <10%, Clin Infect Dis 27:851, 1998.",
        "May need Fluconazole if yeast on Gram stain of sinus aspirate.",
        "Review: Clin Infect Dis 27:463, 1998."
      ]
    }
  ]
}